Therefore, given that SLC7A11 was identified as an independent prognostic factor in RCC and was able to contribute to clinical benefit (Figure 3C–E), introducing SLC7A11 into the traditional prognostic model will improve its accuracy. This evidence concerns the gene SLC7A11 and renal cell carcinoma.